Frontlight ResearchEarly access
Trial site
Utah Kidney Research Institute
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Chronic kidney disease2 trials
- Coronary artery disease1 trial
- Heart failure1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- argenx1 trial
- Boehringer Ingelheim1 trial
- Eli Lilly and Company1 trial
- Takeda1 trial
Running trials
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- IgA nephropathy2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026